USP4 and prostate cancer: In prostate cancer, METTL3 remains the most studied m6A modification regulators, and METTL3 mediates m6A modification of USP4 mRNA at A2696 to promote prostate cancer invasion and metastasis (Chen et al., 2021[31]).